QID 378564

Date Published: 2023-06-09

QID 378564: IpSwitch MOVEit Transfer Multiple SQL Injection Vulnerabilities (June 2023)

MOVEit Transfer is a managed file transfer (MFT) solution developed by Ipswitch. It allows the enterprise to securely transfer files between business partners and customers using SFTP, SCP, and HTTP-based uploads.

Affected Versions:
MOVEit Transfer 2023.0.x versions prior to 2023.0.2
MOVEit Transfer 2022.1.x versions prior to 2022.1.6
MOVEit Transfer 2022.0.x versions prior to 2022.0.5
MOVEit Transfer 2021.1.x versions prior to 2021.1.5
MOVEit Transfer 2021.0.x versions prior to 2021.0.7
MOVEit Transfer 2020.1.x (12.1) special patch available.
MOVEit Transfer 2020.0.x (12.0) or older.

QID Detection Logic: (Authenticated)
This QID checks file version of MOVEit.DMZ.ClassLib.dll to identify the vulnerable versions of the product MOVEit Transfer.

Successful exploitation of this vulnerability could allow an un-authenticated attacker to gain unauthorized access to the MOVEit Transfer database.

CVSS V3 rated as Critical - 9.1 severity.

CVSS V2 rated as Critical - 10 severity.

Solution

Customers are advised to refer to the article Article_000234899 for more information regarding the vulnerability and its related patches.

Vendor References

Article_000234899 - community.progress.com/s/article/MOVEit-Transfer-Critical-Vulnerability-CVE-Pending-Reserve-Status-June-9-2023

CVEs related to QID 378564

CVE-2023-35036 |

Software Advisories

Advisory ID	Software	Component	Link
MOVEit Transfer Critical Vulnerability			community.progress.com/s/article/MOVEit-Transfer-Critical-Vulnerability-CVE-Pending-Reserve-Status-June-9-2023

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].